The mechanisms for the association of the consumption of sugar-sweetened beverages (SSBs) with obesity and type 2 diabetes are only partly understood. The objective of the study was to examine the association of habitual SSB consumption with biomarkers of energy metabolism, including serum glucose, glycated hemoglobin, insulin, insulin resistance [homeostasis model assessment of insulin resistance (HOMA-IR)], and leptin. Data were taken from the Study on Nutrition and Cardiovascular Risk in Spain (ENRICA), a cross-sectional study conducted during 2008-2010 in 7842 individuals representative of the population of Spain aged 18-59 y. Diet was assessed with a validated computerized diet history. Biomarkers were determined in 12-h fasting blood samples. Analyses were performed with linear regression with adjustment for the main confounders, including body mass index (BMI), waist circumference, and morbidity. In men, a 1-serving (200 mL)/d increase in the consumption of SSBs was associated with higher plasma concentrations of insulin (2.14%, P = 0.01), higher HOMA-IR (1.90%, P = 0.04), and higher concentrations of leptin (2.73%, P = 0.01). Among women, these associations were found only in those with a BMI <25 kg/m 2 (insulin: 2.88%, P = 0.004; HOMA-IR: 3.03%, P = 0.01; and leptin: 4.57%, P = 0.01) or with a waist circumference <80 cm (insulin: 2.79%, P = 0.01; HOMA-IR: 3.00%, P = 0.01; and leptin: 3.63%, P = 0.05). In conclusion, the consumption of SSBs was associated with higher concentrations of insulin and leptin and a higher HOMA-IR in men and in nonoverweight women. Insulin resistance and higher leptin may be early markers of metabolic dysfunction associated with SSBs.
Introduction
There is accumulating evidence that sugar-sweetened beverage (SSB) 6 intake increases the risk of obesity and diabetes mellitus (1) (2) (3) . Moreover, the consumption of these beverages has increased steeply during the past decades in many countries (4) (5) (6) , so that SSBs may be contributing to the worldwide epidemic of obesity and diabetes (7, 8) .
The mechanisms of the association of SSB intake with obesity and diabetes are only partly understood. With regard to the effect of SSBs on energy metabolism, SSB intake was shown to increase serum glucose, insulin, and leptin in short-term randomized trials (9) (10) (11) . However, to our knowledge, only 1 longitudinal and 4 cross-sectional studies ascertained the relation between habitual intake of SSBs and biomarkers of glucose metabolism and leptin. In the longitudinal study, SSB intake was associated with impaired fasting glucose after a 4-y follow-up (12) . In the cross-sectional investigations, SSBs were associated with markers of insulin resistance in 1 study in middle-and older-aged adults (13) . Another study reported a direct association of fructose intake with fasting glucose and insulin resistance in U.S. adolescents (14) . A third study found that SSBs were related to higher prevalence of insulin resistance in European adolescents (15) ; and in a final study in middle-aged men, the consumption of SSBs was associated with decreased leptin concentrations (16) . Of note is that none of the above studies investigated if the associations varied with sex, BMI, or waist circumference. This is important because leptin concentrations are higher in women than in men and the concentrations of most markers of glucose metabolism and leptin are higher in obese individuals (17) (18) (19) . Therefore, the aim of this study was to examine the association of habitual consumption of SSBs with markers of glucose metabolism and leptin and to assess whether this association changes with sex and anthropometric variables in a large representative sample of the adult population of Spain.
Participants and Methods

Study design and participants
We analyzed data from the ENRICA (Study on Nutrition and Cardiovascular Risk in Spain), whose methods have been reported elsewhere (20) . In brief, this is a cross-sectional study conducted from 2008 to 2010 in a representative sample of the Spanish population aged $18 y (n = 12,948). Data were collected in 3 stages. First, a phone interview was conducted to obtain information on sociodemographic variables, health behaviors, and diagnosed morbidity. Second, a home visit was made to collect blood and urine samples, which took place 2-4 wk after the interview. And third, another home visit to obtain a complete diet history, including soft drink consumption, and blood pressure and anthropometric measurements was undertaken. The mean time between the first and the second home visits was 10 d. Data were collected by trained and certified personnel. The ENRICA study was approved by the clinical research ethics committees of La Paz University Hospital in Madrid and the Hospital Clínic in Barcelona. All participants gave informed written consent.
Study variables
Soft drink consumption. Information on the beverages consumed in the past year was collected by using a computerized diet history developed from the one used in the EPIC (European Prospective Investigation into Cancer and Nutrition) Spanish cohort (21) . Specifically, we recorded the consumption of the following beverages: carbonated SSBs, including caffeinated colas, caffeine-free colas, and different types of noncola sodas; noncarbonated SSBs, such as fruit punches, lemonade, or other fruit drinks; and artificially sweetened beverages (ASBs; diet or light soft drinks). The diet history included home-based measures and photographs to help estimate the amount of intake per serving. One standard serving of soft drinks was deemed to contain 200 mL. In our validation study, we obtained moderate correlations between consumption of soft drinks estimated from the diet history and consumption estimated from seven 24-h dietary recalls (r = 0.40) (22) . This value was similar to that of other instruments used to measure the usual diet in Spain (23, 24) and permits reliable classification of participants (25) .
Biomarkers. The following biomarkers of energy metabolism were determined in 12-h fasting blood samples: 1) glucose, determined by the glucose oxidase method, by using the analyzer ADVIA 2400 Chemistry System (Siemens); 2) glycated hemoglobin (HbA1c), by using HPLC (ADAMS A1c HA-8160 analyzer; Arkray); 3) insulin, by immunoradiometric assay; and 4) leptin, by an ELISA kit (Diagnosis Biochem Canada). HOMA-IR was calculated by multiplying glucose in mg/dL by insulin in mU/L and dividing by 405 (26) . Laboratory determinations were performed at the Center of Biological Diagnosis of the Hospital Clínic in Barcelona with the use of standard procedures and appropriate quality controls.
Other variables. We also collected data on potential confounders of the study association. These included several sociodemographic variables and health behaviors such as age, sex, educational level, cohabitation, tobacco smoking, sleep duration, physical activity at leisure time (using the EPIC-Spain questionnaire) (27) , and food consumption. For diet, we specifically considered total energy intake, alcohol intake, coffee consumption, and adherence to the Mediterranean diet, as assessed with the Trichopoulou index (28) . Participants also reported if they were following a diet to lose weight during the past year and whether they had lost weight in the past 4 y.
Possible mediators of the study associations were taken into account. Weight, height, and waist circumference were measured under standardized conditions (29) . BMI was calculated as weight in kilograms divided by the height in meters squared. Overweight was defined as BMI $25 kg/m 2 or a waist circumference $80 and 94 cm in women and men, respectively; obesity was defined as BMI $30 kg/m 2 or a waist circumference $88 and 102 cm in women and men, respectively. Finally, we obtained data on morbidity. Hypertension was defined as systolic blood pressure $140 mm Hg, diastolic blood pressure $90 mm Hg, or undergoing treatment for hypertension; and hypercholesterolemia was defined as serum total cholesterol $200 mg/dL (2 g/L) or receiving lipidlowering treatment. Individuals also reported whether they had been diagnosed by a physician with cardiovascular disease, cancer at any site, asthma, chronic bronchitis, sleep apnea, peptic ulcer, cholelithiasis, cirrhosis, osteoarthritis, or periodontal disease.
Statistical analysis
Of the initial sample comprising 12,948 individuals, we excluded 3302 participants aged >60 y because soft drink consumption in older people is very low in Spain. We also excluded 274 individuals with fasting serum glucose $126 mg/dL, diagnosed diabetes, or undergoing treatment with insulin or other hypoglycemic agents. Finally, the following participants were excluded because of missing data: 163 missing biomarker data, 688 missing diet information, and 679 missing data on other study variables. Thus, the analyses were conducted in 7842 individuals.
The analyses were performed with linear regression, in which the dependent variable was each biomarker and the main independent variable was consumption of SSBs. Given that the studied biomarkers did not follow a normal distribution, we used their log-transformed plasma concentrations. Inverse transformations then allowed us to obtain the geometric mean and its 95% CI for each biomarker across categories of SSB consumption [<1 serving (200 mL)/wk, 1-6 servings/ wk, $7 servings/wk]. The study associations were summarized with the percentage of change in biomarker concentration per a 1-serving/d increase in the consumption of soft drinks. Analyses were first adjusted for all variables listed in the above section, except for BMI, waist circumference, and morbidity, which were included in successive steps to understand their contribution to the study associations. In secondary analyses, the association of SSB intake with insulin and HOMA-IR was additionally adjusted for leptin, which might act as a mediator.
The analyses were conducted separately in each sex and in strata defined according to BMI (<25 vs. $25 kg/m 2 ) and waist circumference (<80 and 94 vs. 80 and 94 cm in women and men, respectively). We tested whether the study associations varied with the stratification variables by using the Wald test for the interaction term, defined as the product of SSB consumption by each stratification variable.
We replicated the analyses by using only participants younger than 35 y, because they have the highest consumption of soft drinks and are more likely to keep stable dietary habits than older participants, who may change diet because of increasing health consciousness and the diagnosis of health disorders. Moreover, we examined the study association only among participants who did not follow a diet to lose weight or who did not lose substantial weight (>5 kg) over the preceding 4 y, because dieting and weight loss might have motivated participants to replace SSBs with ASBs. Because of the emerging evidence of an effect of soft drink consumption on cardiovascular disease, cancer, and other morbidities, we repeated the analyses only among individuals without hypertension, hypercholesterolemia, and self-reported diseases. Finally, we replicated all of the analyses using ASBs as the main exposure variable.
Statistical analyses were performed with STATA software (version 11.0; Stata Corp). A 2-tailed P value <0.05 was considered significant. Table 1 presents the age-adjusted characteristics of the study participants according to SSB intake. In comparison with those who consumed <1 serving/wk of SSBs, individuals who drank $7 servings/wk had lower education, higher energy and alcohol intake, less coffee consumption, and lower adherence to the 4 Multivariate + weight variables + morbidity: hypertension, hypercholesterolemia, and self-reported disease (including cardiovascular disease, cancer, asthma or chronic bronchitis, sleep apnea, peptic ulcer, cholelithiasis, cirrhosis, osteoarthritis, and periodontal disease).
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Mediterranean diet. They were also more likely to smoke and less likely to diet. In addition, women who consumed $7 servings/wk of SSBs were more likely to live alone and had a higher frequency of hypertension and self-reported diseases. Tables 2 and 3 show the association between SSB intake and biomarkers for men and women, respectively. No significant association between SSB consumption and glucose or HbA1c concentrations was observed in either sex. Among men, a significant dose-response relation with SSB intake was seen for insulin, HOMA-IR, and leptin. These associations were not modified when BMI, waist circumference, and morbidity were included in the models (change in insulin per 1-serving/d increase in SSBs: 2.14%, P = 0.01; change in HOMA-IR: 1.90%, P = 0.04; and change in leptin: 2.73%, P = 0.01). After additional adjustment for leptin, we observed certain attenuation of the associations between SSBs and insulin (1.54%, P = 0.05) and between SSBs and HOMA-IR (1.13%, P = 0.12). Among women, significance was achieved only for leptin (2.49%, P = 0.03).
In stratified analyses, results for SSB intake in men held regardless of BMI and waist circumference values (Supplemental Table 1 ). In contrast, among women, SSB consumption was associated with the biomarkers only in those with a BMI or waist circumference in the normal range ( Table 4) . In women with a BMI <25 kg/m 2 , a 1-serving/d increase in SSB intake was associated with the following changes in biomarkers: 2.88% (P = 0.003) for insulin, 3.03% (P = 0.01) for HOMA-IR, and 4.57% (P = 0.01) for leptin. The corresponding values in women with a waist circumference <80 cm were 2.79% (P = 0.01), 3.00% (P = 0.01), and 3.63% (P = 0.05). Finally, the results were similar in individuals younger than 35 y and in those who were not dieting, who did not lose substantial weight in the previous 4 y, and who were free of self-reported diagnosed diseases (Supplemental Tables 2 and 3) .
When we examined the characteristics of participants who consumed $7 servings/wk of ASBs, we found that they consumed less alcohol, had a higher BMI and waist circumference, and were more likely to be following a diet and to have lost >5 kg in the past 4 y than those consuming <1 serving/wk (Supplemental Table 4 ). No association was found between consumption of ASBs and the biomarkers studied in men or women (Supplemental Tables 5 and 6 ).
Discussion
In this population-based, cross-sectional study, SSB consumption was associated with higher plasma concentrations of insulin and leptin and a higher HOMA-IR in men. Among women, this association was found only in those with a BMI and waist circumference in the normal range. SSBs contain large amounts of sugars, mostly from high-fructose corn syrup made up of 55% fructose and 45% glucose; this type of rapidly absorbed fructose can overwhelm hepatic metabolic pathways, causing fatty liver and insulin resistance (30) . However, ASBs contain noncaloric, high-intensity sweeteners. Because we did not find any association between ASB consumption and insulin and leptin concentrations, our results suggest that the positive association between SSB intake and the studied biomarkers may be mediated by the fructose added to these beverages. ) and waist circumference (quintiles of cm). 4 Multivariate + weight variables + morbidity: hypertension, hypercholesterolemia, and self-reported disease (including cardiovascular disease, cancer, asthma or chronic bronchitis, sleep apnea, peptic ulcer, cholelithiasis, cirrhosis, osteoarthritis, and periodontal disease).
In several clinical trials, SSBs consumed during 2 to 10 wk impaired insulin sensitivity and lipid metabolism and increased inflammatory markers (9, 10, 31) . Although these studies provide the most reliable causal evidence, only short-term effects were assessed, and the standardization of SSB consumption that occurred in clinical trials did not reflect all sociocultural, economic, and lifestyle factors influencing SSB intake and its effects (32) . Only a few observational studies assessed the association between habitual consumption of SSBs and biomarkers of glucose metabolism. Among participants in the Framingham Heart Study followed during 4 y, Dhingra et al. (12) found that those who consumed $1 serving/d of SSBs had a higher risk of impaired fasting glucose as well as of hypertension, hypertriglyceridemia, and low HDL cholesterol. Also, among 2500 participants in the Framingham Offspring Study, the consumption of $2 servings/d of SSBs was linked to higher fasting insulin and HOMA-IR, independently of the intake of energy, alcohol, and saturated fat (13) . Finally, 2 studies in adolescents found a direct association between SSB consumption and the HOMA-IR (14, 15) .
In our study, after adjusting for several potential confounders, habitual consumption of SSBs was associated with higher insulin and HOMA-IR but not glucose or HbA1c. The lack of association between SSBs and glucose might be due to a physiologic increase in insulin resulting from SSB intake, which counterbalances any increase in glucose. Possibly for the same reason, we found no elevation of HbA1c, which reflects longterm glucose concentrations. Our results also showed an association between SSB intake and leptin concentrations. Leptin is a circulating protein secreted mostly by adipocytes. Leptin is a key regulator of energy homeostasis, which, along with insulin, acts in the hypothalamus and other areas of the brain to reduce energy intake and increase energy expenditure (33) . Thus, higher concentrations of leptin have been considered to be a marker of a healthy metabolic state (34) . However, some studies defined a state of resistance to leptin (35) , implying that higher concentrations of leptin are an indicator of increased body adiposity and impaired energy metabolism. Although fructose was shown to reduce leptin secretion during the first 12 h of intake and up to 24 h afterward (36) , other clinical trials found that the administration of fructose during 4 to 10 wk led to elevations in leptin concentrations in healthy (37) and obese (11) participants. Our results support the hypothesis that habitual SSB consumption may contribute to metabolic dysfunction through stimulation of leptin production. In contrast to our results, de Koning et al. (16) found that leptin concentration decreased by 0.8 mg/L per 1-serving/d increase in SSBs. Possible reasons for this discrepancy are differences in the type of study participants (a population sample vs. a cohort of health professionals) and in dietary patterns (a Mediterranean pattern vs. a westernized pattern).
The fact that SSB intake was associated with insulin resistance and leptin but not with glucose, and that this association was observed only among women in the normal range of BMI and waist circumference, suggests that insulin resistance and higher leptin may be early markers of metabolic dysfunction associated with SSB intake. However, in men, this association held regardless of BMI and waist circumference. A possible reason for this discrepancy might be sex differences in body fat percentage and leptin metabolism, suggested by the much higher leptin concentrations in women than in men. In addition, SSB consumption has been linked to higher insulin resistance (38) and higher risk of hypertension (39) in women than in men. In our study, women in the highest category of SSB consumption also had a higher frequency of hypertension and other chronic diseases, which is consistent with a stronger health effect of SSB intake in women.
There is evidence that insulin resistance increases the risk of diabetes (40) and cardiovascular disease (41) . Although the observed differences in insulin resistance between extreme categories of SSB consumption are of a low magnitude, they might be of public health importance given the high prevalence of SSB consumption. Thus, our results add to the body of evidence in support of public health policies for decreasing SSB consumption and its associated health burden (42) . Finally, in our analyses, ASB consumption did not show an association with these biomarkers. Although ASBs might be an acceptable alternative to SSBs because they do not include fructose and provide few to no calories, their long-term health consequences are still uncertain (3) .
One strength of this study was the ascertainment of soft drink intake by using a validated diet history, including a wide variety of these beverages, in a large sample representative of the adult population of an entire country. Another strength was the adjustment for well-measured confounders, such as adherence to the Mediterranean diet, which has been shown to reduce plasma glucose, insulin, and the HOMA-IR (43) . Among the limitations was the cross-sectional design, which does not allow for establishing causality. Another limitation was that we could not differentiate between habitual consumers of soft drinks and new drinkers. Finally, some error in dietary assessment and biochemical measurement and some residual confounding cannot be ruled out.
In conclusion, in this cross-sectional study the consumption of SSBs was directly associated with higher concentrations of insulin and leptin and higher insulin resistance. This association may be mediated by sugar contained in these beverages because ASBs were not associated with these biomarkers. Last, because this association was particularly evident among women in the normal range of BMI and waist circumference, insulin resistance and higher leptin concentrations may be early markers of metabolic dysfunction associated with SSBs.
